Product
ZG2001
Aliases
ZG2001 Tosilate Tablets
1 clinical trial
2 indications
Indication
Solid TumorIndication
KRAS Mutation-Related TumorsClinical trial
A Phase I/II Dose Escalation Study to Evaluating the Tolerability, Safety, Efficacy and Pharmacokinetics of ZG2001 Tosilate Tablets in Participants With KRAS Mutated Advanced Solid TumoursStatus: Recruiting, Estimated PCD: 2026-02-01